Metabolism of arachidonic acid by cyclooxygenase is one of the primary sources of reactive oxygen species in the ischemic brain. Neuronal overexpression of cyclooxygenase-2 has recently been shown to contribute to neurodegeneration following ischemic injury. In the present study, we examined the possibility that the neuroprotective effects of the cyclooxygenase-2 inhibitor nimesulide would depend upon reduction of oxidative stress following cerebral ischemia. Gerbils were subjected to 5 min of transient global cerebral ischemia followed by 48 h of reperfusion and markers of oxidative stress were measured in hippocampus of gerbils receiving vehicle or nimesulide treatment at three different clinically relevant doses (3, 6 or 12 mg/kg). Compared with vehicle, nimesulide significantly (P B/0.05) reduced hippocampal glutathione depletion and lipid peroxidation, as assessed by the levels of malondialdehyde (MDA), 4-hydroxy-alkenals (4-HDA) and lipid hydroperoxides levels, even when the treatment was delayed until 6 h after ischemia. Biochemical evidences of nimesulide neuroprotection were supported by histofluorescence findings using the novel marker of neuronal degeneration Fluoro-Jade B. Few Fluoro-Jade B positive cells were seen in CA1 region of hippocampus in ischemic animals treated with nimesulide compared with vehicle. These results suggest that nimesulide may protect neurons by attenuating oxidative stress and reperfusion injury following the ischemic insult with a wide therapeutic window of protection. #
Introduction
Neuronal loss following ischemic brain injury is a delayed process in which the primary injury is followed by a prolonged period of secondary neurodegeneration resulting in neurological dysfunction. It has been shown that pyramidal neurons in the hippocampal CA1 region are particularly sensitive to injury due to transient global ischemia, and neuronal cell death occurs within days after ischemia/reperfusion (Kirino, 1982; Schmidt-Kastner and Freund, 1991) . This phenomenon is referred to as delayed neuronal death (DND). Although not fully understood, ischemia-induced DND is probably associated with a myriad of biochemical events initially triggered by the extracellular accumulation of glutamate. In turn, this leads to membrane depolarization, increased concentrations of intracellular calcium, overproduction of reactive oxygen species and oxidative damage (Kitagawa et al., 1990; Nakamura et al., 1999; Urabe et al., 2000; Chan, 2001) .
Many factors, including high content of polyunsaturated fatty acids, high rate of oxidative metabolic activity, intense production of reactive oxygen metabolites, relatively low antioxidant capacity and low repair mechanism activity, suggest that neurons in the central nervous system are particularly prone to oxidative stress (Halliwell and Gutteridge, 1985; Liu, 2003) . A large body of experimental evidences has demonstrated the involvement of reactive oxygen species in cerebral ischemia/reperfusion and cell death mechanisms (Kitagawa et al., 1990; Facchinetti et al., 1998; Chan, 2001) .
Previous studies have shown that one of the primary sources of reactive oxygen species in the ischemic brain is through the metabolism of arachidonic acid by cyclooxygenase (Nelson et al., 1992; Busija et al., 1998; Chan, 2001) . Two isoforms of cyclooxygenase have been described: cyclooxygenase-1 and cyclooxygenase-2. Cy-
